{
    "2019-09-24": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Johnson & Johnson (JNJ) Stock Moves -0.14%: What You Should Know",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Stock Moves",
                        "-0.14%"
                    ],
                    "sentiment_score": -0.1,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "5 Stocks That Could Get Crushed By Opioid Lawsuit Tidal Wave",
                "features": {
                    "keywords": [
                        "Opioid Lawsuit",
                        "Crushed",
                        "Stocks"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "\"Healthy\" Dividend Aristocrats: 6 Great Health-Care Dividends",
                "features": {
                    "keywords": [
                        "Dividend Aristocrats",
                        "Health-Care",
                        "Great"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AstraZeneca Gets CHMP Nod for Forxiga/Onglyza Combo Tablet",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "CHMP Nod",
                        "Forxiga/Onglyza"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Fast-growing Atlanta biomedical company hires new CEO",
                "features": {
                    "keywords": [
                        "Atlanta",
                        "biomedical",
                        "new CEO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biomedical"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Mallinckrodt's StrataGraft Tissue Phase III Data Positive",
                "features": {
                    "keywords": [
                        "Mallinckrodt",
                        "StrataGraft",
                        "Phase III",
                        "Positive"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}